Application of Deep Learning to Predict Standardized Uptake Value Ratio and Amyloid Status on ¹⁸F-Florbetapir PET Using ADNI Data

References

1. 1.↵
   1. Mayeux R,
   2. Stern Y

   . Epidemiology of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012;2:a006239 doi:10.1101/cshperspect.a006239

   Abstract/FREE Full Text
2. 2.↵
   1. Hyman B

   . The neuropathological diagnosis of Alzheimer’s disease: clinical-pathological studies. Neurobiol Aging 1997;18:S27–32 doi:10.1016/S0197-4580(97)00066-3 pmid:9330982

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Braak H,
   2. Braak E

   . Diagnostic criteria for neuropathologic assessment of Alzheimer’s disease. Neurobiol Aging 1997;18:S85–88 doi:10.1016/S0197-4580(97)00062-6 pmid:9330992

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Cummings BJ,
   2. Pike CJ,
   3. Shankle R, et al

   . β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease. Neurobiol Aging 1996;17:921–33 doi:10.1016/S0197-4580(96)00170-4 pmid:9363804

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Palmqvist S,
   2. Zetterberg H,
   3. Blennow K, et al

   . Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol 2014;71:1282–89 doi:10.1001/jamaneurol.2014.1358 pmid:25155658

   CrossRefPubMed
6. 6.↵
   1. Johnson KA,
   2. Sperling RA,
   3. Gidicsin CM, et al

   . Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement 2013;9:S72–83 doi:10.1016/j.jalz.2012.10.007 pmid:23375563

   CrossRefPubMed
7. 7.↵
   1. Camus V,
   2. Payoux P,
   3. Barré L, et al

   . Using PET with 18 F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging 2012;39:621–31 doi:10.1007/s00259-011-2021-8 pmid:22252372

   CrossRefPubMed
8. 8.↵
   1. Landau SM,
   2. Mintun MA,
   3. Joshi AD; Alzheimer's Disease Neuro-imaging Initiative

   . Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 2012;72:578–86 doi:10.1002/ana.23650 pmid:23109153

   CrossRefPubMed
9. 9.↵
   1. Landau SM,
   2. Lu M,
   3. Joshi AD, et al

   . Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid. Ann Neurol 2013;74:826–36 doi:10.1002/ana.23908 pmid:23536396

   CrossRefPubMed
10. 10.↵
    1. Mormino EC,
    2. Kluth JT,
    3. Madison CM, et al

    . Episodic memory loss is related to hippocampal-mediated β-amyloid deposition in elderly subjects. Brain 2009;132:1310–23 doi:10.1093/brain/awn320 pmid:19042931

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Jagust WJ,
    2. Landau SM,
    3. Shaw LM, et al

    . Relationships between biomarkers in aging and dementia. Neurology 2009;73:1193–99 doi:10.1212/WNL.0b013e3181bc010c pmid:19822868

    CrossRefPubMed
12. 12.↵
    1. Landau S,
    2. Jagust W

    . Florbetapir processing methods. Alzheimer’s Disease Neuroimaging Initiative; 2015. https://adni.bitbucket.io/reference/docs/UCBERKELEYAV45/ADNI_AV45_Methods_JagustLab_06.25.15.pdf
13. 13.↵
    1. Paszke A,
    2. Gross S,
    3. Chintala S, et al

    . Automatic Differentiation in PyTorch. In: NIPS Autodiff Workshop; 2017
14. 14.↵
    1. He K,
    2. Zhang X,
    3. Ren S, et al

    . Deep residual learning for image recognition. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition; 2016;770–78
15. 15.↵
    1. Kingma DP,
    2. Ba J,
    3. Adam A

    . Method for stochastic optimization. arXiv preprint arXiv:14126980; 2014
16. 16.↵
    1. Yosinski J,
    2. Clune J,
    3. Bengio Y, et al

    . How transferable are features in deep neural networks? Advances in Neural Information Processing Systems 2014;27:3320–28
17. 17.↵
    1. Shin HC,
    2. Roth HR,
    3. Gao M, et al

    . Deep convolutional neural networks for computer-aided detection: CNN architectures, dataset characteristics and transfer learning. IEEE Trans Med Imaging 2016;35:1285–98 doi:10.1109/TMI.2016.2528162 pmid:26886976

    CrossRefPubMed
18. 18.↵
    1. Deng J,
    2. Dong W,
    3. Socher R, et al

    . Imagenet: A large-scale hierarchical image database. In: 2009 IEEE Conference on Computer Vision and Pattern Recognition IEEE 2009;248–55
19. 19.↵
    1. Krizhevsky A,
    2. Sutskever I,
    3. Hinton GE

    . Imagenet classification with deep convolutional neural networks. Advances in Neural Information Processing Systems 2012;25:1097–1105
20. 20.↵
    1. Levin CS

    . Promising new photon detection concepts for high-resolution clinical and preclinical PET. J Nucl Med 2012;53:167–70 doi:10.2967/jnumed.110.084343 pmid:22302960

    Abstract/FREE Full Text
21. 21.↵
    1. Kang H,
    2. Kim WG,
    3. Yang GS, et al

    . VGG-based BAPL score classification of 18F-florbetaben amyloid brain PET. BSL 2018;24:418–25 doi:10.15616/BSL.2018.24.4.418

    CrossRef
22. 22.↵
    1. Cattell L,
    2. Platsch G,
    3. Pfeiffer R, et al

    . Classification of amyloid status using machine learning with histograms of oriented 3D gradients. Neuroimage Clin 2016;12:990–1003 doi:10.1016/j.nicl.2016.05.004 pmid:27995065

    CrossRefPubMed
23. 23.↵
    1. Choi H,
    2. Jin KH

    . Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging. Behavioural Brain Research 2018;344:103–09 doi:10.1016/j.bbr.2018.02.017

    CrossRef
24. 24.↵
    1. Ding Y,
    2. Sohn JH,
    3. Kawczynski MG, et al

    . A deep learning model to predict a diagnosis of Alzheimer disease by using 18F-FDG PET of the brain. Radiology 2018;290:456–64 doi:10.1148/radiol.2018180958

    CrossRef
25. 25.↵
    1. Singh S,
    2. Srivastava A,
    3. Mi L, et al

    . Deep-learning-based classification of FDG-PET data for Alzheimer’s disease categories. In: 13th International Conference on Medical Information Processing and Analysis. International Society for Optics and Photonics 2017;10572:105720J
26. 26.↵
    1. Lu D,
    2. Popuri K,
    3. Ding GW, et al

    . Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer’s disease. Med Image Anal 2018;46:26–34 doi:10.1016/j.media.2018.02.002 pmid:29502031

    CrossRefPubMed
27. 27.↵
    1. Rabinovici GD,
    2. Gatsonis C,
    3. Apgar C, et al

    . Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA 2019;321:1286–94 doi:10.1001/jama.2019.2000

    CrossRef
28. 28.↵
    1. Adebayo J,
    2. Gilmer J,
    3. Muelly M, et al

    . Sanity checks for saliency maps. Advances in Neural Information Processing Systems 2018;31:9505–15
29. 29.↵
    1. Schwarz CG,
    2. Jones DT,
    3. Gunter JL, et al

    . Contributions of imprecision in PET/MRI rigid registration to imprecision in amyloid PET SUVR measurements. Hum Brain Mapp 2017;38:3323–36